[go: up one dir, main page]

US20010054574A1 - Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same - Google Patents

Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same Download PDF

Info

Publication number
US20010054574A1
US20010054574A1 US09/916,560 US91656001A US2001054574A1 US 20010054574 A1 US20010054574 A1 US 20010054574A1 US 91656001 A US91656001 A US 91656001A US 2001054574 A1 US2001054574 A1 US 2001054574A1
Authority
US
United States
Prior art keywords
coal tar
distillation
tar extract
ppm
dermatological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/916,560
Inventor
Roger Navarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/916,560 priority Critical patent/US20010054574A1/en
Publication of US20010054574A1 publication Critical patent/US20010054574A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
    • B60K15/00—Arrangement in connection with fuel supply of combustion engines or other fuel consuming energy converters, e.g. fuel cells; Mounting or construction of fuel tanks
    • B60K15/03—Fuel tanks
    • B60K15/04—Tank inlets
    • B60K15/05—Inlet covers
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C1/00—Working-up tar
    • C10C1/04—Working-up tar by distillation
    • C10C1/16—Winning of pitch
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00—Working-up pitch, asphalt, bitumen
    • C10C3/06—Working-up pitch, asphalt, bitumen by distillation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Definitions

  • the present invention relates to a coal tar extract with a reduced content of polycyclic aromatic hydrocarbons, to a process for obtaining it and to dermocosmetic compositions containing it.
  • coal tar means the by-product of the destructive distillation of bituminous coal distilling between at 300 and 370° C. This is a black viscous liquid whose characteristic odor resembles that of naphthalene.
  • coal pitch means the residue from the distillation of coal tar.
  • Crude coal tar contains a large proportion of polycyclic aromatic hydrocarbons (PAH) of the order of 100,000 ppm.
  • PAH polycyclic aromatic hydrocarbons
  • Among the predominant PAHs which have been identified are fluoranthene, pyrene, anthracene, phenanthrene, fluorene, 1,2-benzofluorene, 2,3-benzofluorene, 1,2-benzanthracene, chrysene, benzo(k)-fluoranthene, benzo(a)fluoranthene, benzo(b)fluoranthene, benzo(e)pyrene, benzo(a)pyrene (BaP), indeno(1,2,3,c,d)pyrene, 1,2,5,6-dibenzanthracene, benzo(6)chrysene and benzo(g,h,i)perylene, the last thirteen compounds having toxic properties.
  • Coal tar is commonly used in antidandruff treatment, in the treatment of certain types of dermatitis such as eczema, lichenification and psoriasis. Before being incorporated into dermatological compositions, coal tar undergoes a purification intended to make it colorless, odorless and substantially free of irritant properties.
  • Patent U.S. Pat. No. 3,766,052 published on Oct. 16, 1973 describes a process for purifying commercially available coal tar, which comprises mixing the said coal tar with a C 15 -C 22 fatty acid ester, adding squalane or squalene, and recovering the purified coal tar in the form of the supernatant liquid.
  • the coal tar obtained has a viscosity of between 10 and 50 mPa.s and a density at 25° C. of between 0.88 and 0.95. It is used as an active ingredient in dermatological compositions in a proportion from 1 to 10% by weight.
  • Patent U.S. Pat. No. 3,928,579 (Warner Lambert Co.) published on Dec. 23, 1975 describes a process for purifying crude coal tar, which consists:
  • the solvents used are C 3 -C 6 alkanes or CFCs.
  • the purified coal tar is incorporated in the dermatological composition.
  • Patent application JP-55 153 710 published on Nov. 30, 1980 describes a cosmetic skin composition containing, as active ingredient, purified tar obtained by distillation of mineral, animal or plant tar under reduced pressure, by diazotization and then by hydrolysis or heating.
  • the tars used are coal tar and soybean tar.
  • Patent application EP-A-465,434 describes tar oil obtained by fractional distillation of naphthalene oil on three rectification columns in series between 230 and 330° C.
  • the naphthalene oil itself is obtained from the distillation of coal pitch.
  • this extract can contain a BaP percentage of less than 2 ppm (parts per million). However, at the industrial scale, a BaP percentage of about 20 ppm will be selected.
  • the present invention relates to a coal tar extract with a reduced content of both PAH and BaP.
  • the coal tar extract according to the invention is characterized by a maximum PAH content of about ten ppm and by a maximum BaP content of about a few ppm.
  • the coal tar extracted according to the invention is preferably characterized by a PAH content of less than about 4 ppm and a BaP content of less than about 1 ppm.
  • the present invention also relates to a process for obtaining the said coal tar extract from crude coal tar which uses at least two distillation systems connected in series.
  • a thin-film evaporator is advantageously chosen as the first distillation system, and/or a distillation column as the second system.
  • the distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, at a temperature of between 198 and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h.
  • the distillation yield according to the invention using a thin-film evaporator coupled to a distillation column is between 20 and 25% by weight.
  • Crude coal tar is commercially available and corresponds to the definition in the French Pharmacopea and/or in the US Pharmacopea. Its respective contents of PAH and of BaP are about 93,000 and 2000-10,000 ppm.
  • the present invention relates to cosmetic or dermatological compositions containing the coal tar extract according to the invention, preferably in a proportion of from 0.1 to 10% by weight.
  • a cosmetic or dermatological composition containing 0.5% of coal tar extract with 1 ppm of BaP has respective contents of PAH and BaP of about 15 and 2 ppb (parts per billion).
  • compositions are proposed under the same therapeutic indications as crude coal tar.
  • Example 1 SHAMPOO PURIFIED WATER qs 100 g PULVERIZED SALICYCLIC ACID 1.50 g UNDECYLENIC DERIVATIVE 1 to 3 g QUATERNARY POLYMER 0.5 to 1 g ETHOXYLATED SODIUM ALKYL SULFATE 9 g POLYSORBATE-20 5 to 7 g FATTY ACID ETHANOLAMIDE PEG-6000 DISTEARATE 5 g ALKYLAMIDO BETAINE 1.5 g COCOAMPHODIACETATE 3.5 g DISODIUM EDTA 0.2 g 20 POE SORBITAN MONOLAURATE 5 g FRAGRANCE QS DYE QS COAL TAR 0.1 ⁇ g 2.50
  • Example 2 SHAMPOO WATER qs 100 g SODIUM LAURETH SULFATE 8 g POLYSORBATE 7 g PEG-150 DISTEARATE 4

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Sustainable Development (AREA)
  • General Chemical & Material Sciences (AREA)
  • Structural Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Civil Engineering (AREA)
  • Sustainable Energy (AREA)
  • Combustion & Propulsion (AREA)
  • Transportation (AREA)
  • Mechanical Engineering (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns a coal tar extract with reduced polycyclic aromatic hydrocarbon content and a method for obtaining same using two sequentially linked distillation systems. The invention also concerns cosmetic and dermatological preparations containing said resulting coal tar extract.

Description

  • The present invention relates to a coal tar extract with a reduced content of polycyclic aromatic hydrocarbons, to a process for obtaining it and to dermocosmetic compositions containing it. [0001]
  • The term “coal tar” means the by-product of the destructive distillation of bituminous coal distilling between at 300 and 370° C. This is a black viscous liquid whose characteristic odor resembles that of naphthalene. [0002]
  • The term “coal pitch” means the residue from the distillation of coal tar. [0003]
  • Crude coal tar contains a large proportion of polycyclic aromatic hydrocarbons (PAH) of the order of 100,000 ppm. Among the predominant PAHs which have been identified are fluoranthene, pyrene, anthracene, phenanthrene, fluorene, 1,2-benzofluorene, 2,3-benzofluorene, 1,2-benzanthracene, chrysene, benzo(k)-fluoranthene, benzo(a)fluoranthene, benzo(b)fluoranthene, benzo(e)pyrene, benzo(a)pyrene (BaP), indeno(1,2,3,c,d)pyrene, 1,2,5,6-dibenzanthracene, benzo(6)chrysene and benzo(g,h,i)perylene, the last thirteen compounds having toxic properties. [0004]
  • Coal tar is commonly used in antidandruff treatment, in the treatment of certain types of dermatitis such as eczema, lichenification and psoriasis. Before being incorporated into dermatological compositions, coal tar undergoes a purification intended to make it colorless, odorless and substantially free of irritant properties. [0005]
  • Many processes for purifying coal tar are described in the literature. [0006]
  • Patent U.S. Pat. No. 3,766,052 (Warner Lambert Co.) published on Oct. 16, 1973 describes a process for purifying commercially available coal tar, which comprises mixing the said coal tar with a C[0007] 15-C22 fatty acid ester, adding squalane or squalene, and recovering the purified coal tar in the form of the supernatant liquid. The coal tar obtained has a viscosity of between 10 and 50 mPa.s and a density at 25° C. of between 0.88 and 0.95. It is used as an active ingredient in dermatological compositions in a proportion from 1 to 10% by weight.
  • Patent U.S. Pat. No. 3,928,579 (Warner Lambert Co.) published on Dec. 23, 1975 describes a process for purifying crude coal tar, which consists: [0008]
  • 1) of an extraction with a volatile solvent or mixture of solvents whose kauri butanol number is less than 75 and whose boiling point is less than 80° C., [0009]
  • 2) of a filtration, and then [0010]
  • 3) of an evaporation of the volatile solvent(s). [0011]
  • The solvents used are C[0012] 3-C6 alkanes or CFCs.
  • The purified coal tar is incorporated in the dermatological composition. [0013]
  • Patent application JP-55 153 710 (Fujunaga Seiyaku) published on Nov. 30, 1980 describes a cosmetic skin composition containing, as active ingredient, purified tar obtained by distillation of mineral, animal or plant tar under reduced pressure, by diazotization and then by hydrolysis or heating. The tars used are coal tar and soybean tar. [0014]
  • The distillation carried out from 50 to 120° C. under a vacuum of 5-10 mmHg allows the mutagenic properties of the tar to be reduced by a factor of 20. Diazotization with an excess of nitrite followed by an increase in temperature and optionally a hydrolysis makes it possible to reduce the mutagenic properties of the tar by a factor of 90. [0015]
  • Among the PAHs contained in coal tar whose toxic properties have been recognized, it has been found that BaP exhibits carcinogenic properties in the event of prolonged use. [0016]
  • Patent application EP-A-465,434 describes tar oil obtained by fractional distillation of naphthalene oil on three rectification columns in series between 230 and 330° C. The naphthalene oil itself is obtained from the distillation of coal pitch. [0017]
  • At the experimental stage, this extract can contain a BaP percentage of less than 2 ppm (parts per million). However, at the industrial scale, a BaP percentage of about 20 ppm will be selected. [0018]
  • The present invention relates to a coal tar extract with a reduced content of both PAH and BaP. [0019]
  • The coal tar extract according to the invention is characterized by a maximum PAH content of about ten ppm and by a maximum BaP content of about a few ppm. [0020]
  • The coal tar extracted according to the invention is preferably characterized by a PAH content of less than about 4 ppm and a BaP content of less than about 1 ppm. [0021]
  • The present invention also relates to a process for obtaining the said coal tar extract from crude coal tar which uses at least two distillation systems connected in series. [0022]
  • A thin-film evaporator is advantageously chosen as the first distillation system, and/or a distillation column as the second system. [0023]
  • The distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, at a temperature of between 198 and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h. [0024]
  • The column distillation following distillation on a thin-film evaporator is carried out at between 260 and 320° C. [0025]
  • The distillation yield according to the invention using a thin-film evaporator coupled to a distillation column is between 20 and 25% by weight. [0026]
  • Crude coal tar is commercially available and corresponds to the definition in the French Pharmacopea and/or in the US Pharmacopea. Its respective contents of PAH and of BaP are about 93,000 and 2000-10,000 ppm. [0027]
  • The present invention relates to cosmetic or dermatological compositions containing the coal tar extract according to the invention, preferably in a proportion of from 0.1 to 10% by weight. [0028]
  • A cosmetic or dermatological composition containing 0.5% of coal tar extract with 1 ppm of BaP has respective contents of PAH and BaP of about 15 and 2 ppb (parts per billion). [0029]
  • The said compositions are proposed under the same therapeutic indications as crude coal tar.[0030]
  • The examples which follow illustrate the invention without limiting its scope. [0031]
    Example 1: SHAMPOO
    PURIFIED WATER qs 100 g
    PULVERIZED SALICYCLIC ACID 1.50 g
    UNDECYLENIC DERIVATIVE 1 to 3 g
    QUATERNARY POLYMER 0.5 to 1 g
    ETHOXYLATED SODIUM ALKYL SULFATE 9 g
    POLYSORBATE-20 5 to 7 g
    FATTY ACID ETHANOLAMIDE
    PEG-6000 DISTEARATE 5 g
    ALKYLAMIDO BETAINE 1.5 g
    COCOAMPHODIACETATE 3.5 g
    DISODIUM EDTA 0.2 g
    20 POE SORBITAN MONOLAURATE 5 g
    FRAGRANCE QS
    DYE QS
    COAL TAR 0.1 → g
    2.50
    Example 2: SHAMPOO
    WATER qs 100 g
    SODIUM LAURETH SULFATE 8 g
    POLYSORBATE 7 g
    PEG-150 DISTEARATE 4 g
    SODIUM UNDECYLENAMIDO
    MEA-SULFOSUCCINATE 3 g
    SODIUM COCOAMPHODIACETATE 3 g
    SALICYCLIC ACID 1.5 g
    FRAGRANCE 0.5 g
    T.E.A.-HYDROLYZED COCOYL-COLLAGEN 1 g
    COAL TAR 0.1 → 1 g
    Example 3: LOTION
    WATER qs 100 ml
    SD-ALCOHOL 39-C 63 ml
    FRAGRANCE 0.20 g
    VINYL ACETATE/CROTONIC ACID COPOLYMER 0.15 g
    PEG-13 OCTANOATE 0.10 g
    LAURYLPYRIDINIUM CHLORIDE 0.05 g
    COAL TAR 0.1 → 1 g
    Example 4: CREAM
    WATER qs 100 g
    PEG-40 SORBITAN LANOLATE 7.5 g
    PARAFFIN 5 g
    PROPYLENE GLYCOL 5 g
    CETYL ALCOHOL 3 g
    POLYSORBATE 3 g
    LANOLIN 2 g
    SALICYCLIC ACID 1.5 g
    FRAGRANCE 0.4 g
    COAL TAR 0.1 → 3 g
    Example 5: OIL
    MINERAL OIL qs 100 g
    DIBUTYL ADIPATE 15 g
    CAPRYLIC/CAPRIC TRIGLYCERIDE 10 g
    COAL TAR 0.1 → 2 g
    Example 6: SYNDET
    SODIUM HEMISULFOSUCCINATE qs 100 g
    SODIUM ISOTHIONATE 20 g
    WAX OF MINERAL ORIGIN 12 g
    CETYL ALCOHOL 13 g
    WHEAT STARCH 20 g
    PINE TAR 0.3 g
    CADE TAR 0.3 g
    SALICYCLIC ACID 2 g
    ZINC OXIDE 5 g
    COAL TAR 0.1 → 2 g
    Example 7: MOUSSE
    DEMINERALIZED WATER qs 100 g
    GUAR GUM 0.10 g
    JOJOBA OIL 2 g
    ETHYLHEXYL P-METHOXYCINNAMATE 1 g
    VINYLPYRROLIDONE/DMAE METHACRYLATE 1 g
    PVP HEXADECENE COPOLYMER 2 g
    DIMETHYL/TRIMETHYL-POLYSILOXANE 1 g
    CETRIMONIUM BROMIDE 0.40 g
    FRAGRANCE 0.15 g
    COAL TAR 0.1 → 2 g
    Example 8: EMOLLIENT SOLUTION
    PROPYLENE GLYCOL qs 100 g
    CADE TAR 10 g
    PINE TAR 10 g
    POLYSORBATE 20 g
    POLYETHOXYLATED COCONUT FATTY ESTERS 10 g
    POLYETHOXYLATED ALKYLPHENOL 10 g
    FRAGRANCE 1 g
    COAL TAR 0.1 → 5 g
    Example 9: GELLED BODY OIL
    CAPRYLIC/CAPRIC TRIGLYCERIDE 20 → 30 g
    MINERAL OIL 36 g
    PETROLATUM 15 g
    PEG-40 SORBITOL HEXAOLEATE 8 g
    QUATERNIUM-18 HECTORITE 5 g
    HYDROGENATED TALLOWETH-60
    MYRISTYL GLYCOL 5 g
    FRAGRANCE 0.5 g
    BENZOIC ACID 0.3 g
    PROPYL GALLATE 0.02 g
    COAL TAR 0.1 → 2 g

Claims (8)

1. Coal tar extract, characterized in that its maximum content of polycyclic aromatic hydrocarbons is about ten parts per million (ppm) and its maximum content of benzo(a)pyrene is about a few ppm.
2. Coal tar extract according to
claim 1
, characterized in that its content of polycyclic aromatic hydrocarbons is less than about 4 ppm and its content of benzo(a)pyrene is less than about 1 ppm.
3. Process for obtaining a coal tar extract according to
claim 1
 or
2
, from crude coal tar, characterized in that it uses at least two distillation systems connected in series.
4. Process according to
claim 3
, characterized in that the first system is a thin-film evaporator and/or the second system is a distillation column.
5. Process according to
claim 4
, characterized in that the distillation on a thin-film evaporator is carried out under a pressure of 5 to 7 mmHg, between 198° C. and 200° C., and at a crude coal tar feed rate equal to 18 to 19 kg/h.
6. Process according to
claim 5
, characterized in that the distillation on a distillation column following distillation on a thin-film evaporator is carried out at from 260° C. to 320° C.
7. Cosmetic or dermatological compositions containing a coal tar extract according to
claim 1
 or
2
 or obtained by the process according to one of
claims 3
 to
6
.
8. Cosmetic or dermatological compositions according to
claim 7
, characterized in that they contain 0.1 to 10% by weight of coal tar extract.
US09/916,560 1997-03-11 2001-07-27 Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same Abandoned US20010054574A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/916,560 US20010054574A1 (en) 1997-03-11 2001-07-27 Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9702835 1997-03-11
FR9702835A FR2760637B1 (en) 1997-03-11 1997-03-11 COAL TAR EXTRACT WITH REDUCED AROMATIC HYDROCARBON CONTENT, PROCESS FOR OBTAINING AND DERMO-COSMETIC PREPARATIONS
US09/380,958 US6319392B1 (en) 1997-03-11 1998-03-11 Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions
US09/916,560 US20010054574A1 (en) 1997-03-11 2001-07-27 Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/380,958 Continuation US6319392B1 (en) 1997-03-11 1998-03-11 Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions

Publications (1)

Publication Number Publication Date
US20010054574A1 true US20010054574A1 (en) 2001-12-27

Family

ID=9504586

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/380,958 Expired - Lifetime US6319392B1 (en) 1997-03-11 1998-03-11 Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions
US09/916,560 Abandoned US20010054574A1 (en) 1997-03-11 2001-07-27 Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/380,958 Expired - Lifetime US6319392B1 (en) 1997-03-11 1998-03-11 Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions

Country Status (5)

Country Link
US (2) US6319392B1 (en)
EP (1) EP0964901A1 (en)
CA (1) CA2284871A1 (en)
FR (1) FR2760637B1 (en)
WO (1) WO1998040447A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120237453A1 (en) * 2002-10-25 2012-09-20 Foamix Ltd. Sensation modifying topical composition foam
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
RU2177791C1 (en) * 2000-06-15 2002-01-10 Щербаков Александр Борисович Method of preparing tar applicable for medical destinations
US7033485B2 (en) * 2001-05-11 2006-04-25 Koppers Industries Of Delaware, Inc. Coal tar and hydrocarbon mixture pitch production using a high efficiency evaporative distillation process
US20050095378A1 (en) * 2003-11-03 2005-05-05 Scarpone Stephen P. Hybrid coatings derived from bituminous and petroleum bases
US11248172B2 (en) 2019-07-23 2022-02-15 Koppers Delaware, Inc. Heat treatment process and system for increased pitch yields

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928579A (en) * 1974-11-25 1975-12-23 Warner Lambert Co Process for the purification of coal tar
JPS55153710A (en) * 1979-05-17 1980-11-29 Fujinaga Seiyaku Kk Skin cosmetic
US4409094A (en) * 1980-08-08 1983-10-11 Massachusetts Institute Of Technology Process for detoxifying coal tars
EP0067224B1 (en) * 1980-12-10 1985-09-04 Nippon Steel Chemical Co. Ltd. Process for producing dibenzofuran
IT1243219B (en) * 1990-06-26 1994-05-24 Margaritelli Spa DISTILLED, FRACTIONATED AND RECTIFIED TAR OIL TO BE USED FOR THE ECOLOGICAL IMPREGNATION OF WOOD.
DE4112955A1 (en) * 1991-04-20 1992-10-22 Ruetgerswerke Ag STEINKOHLENTEERPECH, ITS MANUFACTURE AND USE
DE4119170C2 (en) * 1991-06-11 2002-04-25 Geb Herber Miltner Remedies for atopic dermatitis
US6010617A (en) * 1992-11-13 2000-01-04 Mobil Oil Corporation Process for producing non-carcinogenic coal-tar-derived products
US5746906A (en) * 1995-08-10 1998-05-05 Koppers Industries, Inc. Coal tar pitch blend having low polycyclic aromatic hydrocarbon content and method of making thereof

Cited By (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9320705B2 (en) * 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20120237453A1 (en) * 2002-10-25 2012-09-20 Foamix Ltd. Sensation modifying topical composition foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US12138311B2 (en) 2009-10-02 2024-11-12 Journey Medical Corporation Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
US6319392B1 (en) 2001-11-20
FR2760637A1 (en) 1998-09-18
FR2760637B1 (en) 1999-05-28
CA2284871A1 (en) 1998-09-17
EP0964901A1 (en) 1999-12-22
WO1998040447A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
US6319392B1 (en) Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions
EP2005939A1 (en) Cosmetic and dermatological preparations with a percentage of molecular oxygen and perfume substances
EP0688210B1 (en) Use of carnosine in combination with urocanic acid for treatment of photodermatoses
DE3100064A1 (en) COSMETIC PREPARATION FOR TREATING THE SKIN AND HAIR
KR100325317B1 (en) Pharmaceutical and cosmetic antiacne formulations containing plant extracts (Krameria triandra or Mesua ferrea)
DE68903887T2 (en) TRANSPARENT COSMETIC EMULSION.
JP2007077079A (en) Skin care preparation for moisturizing or improving chapped skin
WO2011124244A2 (en) Microbiologically stable, easily applicable preparations comprising active substances susceptible to degradation
EP0586961B1 (en) Cosmetic and dermatologic formulations containing an effective amount of cis urocanic acid
US5037641A (en) Beauty preparations having anti-fading effect and a process for preparing the same
EP0911019B1 (en) Deodorizing compositions based on flavone derivatives and/or flavanone derivatives, especially flavonoids
DE69314463T2 (en) SKIN REGENERATING COSMETIC COMPOSITION
KR102247589B1 (en) Cosmetic composition for improving skin comprising the moluccella laevis extraction and the hololeion maximowiczii Kitam. extraction as an effective ingredient
DE10032165A1 (en) Use of physiologically tolerable sulfinic acids as antioxidant or free radical scavenger in cosmetic or dermatological preparations
EP2090296B1 (en) Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy
EP3111919B1 (en) Emulsions containing cationic emulsifiers based on mdipa esterquats
EP1069884A1 (en) Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids
DE69406475T2 (en) Use of derivatives of 6,6 dimethyl 2-acylcyclohex 4 en 1,3-diones in sunscreens
DE19739349A1 (en) Use of troxerutin as antioxidant and/or radical scavenger
JPH0615449B2 (en) External water phase type cosmetics
WO2007096090A1 (en) Active substance combinations of hydroxymatairesinol, phenoxyethanol and, if desired, glycerin
JP3491755B1 (en) External preparation for skin
DE10151247A1 (en) Refreshing cosmetic or dermatological preparation is an O/W gel emulsion containing hydrocolloids together with lipids, emulsifiers and diastereomers of menthol and/or menthol itself
EP2082733A1 (en) Use of lipid components against pollen allergies
EP0049424B1 (en) Bioactive composition containing vegetable agents

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION